Fredericksen, R. J.
Baker, R.
Sibley, A.
Estadt, A. T.
Colston, D.
Mixson, L. S.
Walters, S.
Bresett, J.
Levander, X. A.
Leichtling, G.
Davy-Mendez, T.
Powell, M.
Stopka, T. J.
Pho, M.
Feinberg, J.
Ezell, J.
Zule, W.
Seal, D.
Cooper, H. L. F.
Whitney, B. M.
Delaney, J. A. C.
Crane, H. M.
Tsui, J. I.
Funding for this research was provided by:
National Institute on Drug Abuse (U24DA048538, UG3DA044831, UH3DA044822, UH3DA044822, UG3DA044823, U24DA048538, UG3DA044829, UG3DA044829, UG3DA044831, UG3DA044831, U24DA048538, UG3DA044830, UG3DA044829, UG3DA044825, UG3DA044829, UG3DA044823, UG3DA044826, UG3DA044798, U24DA048538, U24DA048538, U24DA048538, U24DA048538)
Agency for Healthcare Research and Quality (K12HS026370)
Article History
Received: 9 June 2023
Accepted: 12 March 2024
First Online: 1 April 2024
Declarations
:
: All studies had local institutional review board approval.
: Not applicable.
: No competing declared.